1.14
前日終値:
$0.9975
開ける:
$0.97
24時間の取引高:
7.59M
Relative Volume:
1.61
時価総額:
$136.96M
収益:
-
当期純損益:
$-225.14M
株価収益率:
-0.5816
EPS:
-1.96
ネットキャッシュフロー:
$-192.27M
1週間 パフォーマンス:
+17.16%
1か月 パフォーマンス:
+57.44%
6か月 パフォーマンス:
+7.55%
1年 パフォーマンス:
+33.90%
Invivyd Inc Stock (IVVD) Company Profile
IVVD を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
IVVD
Invivyd Inc
|
1.14 | 208.85M | 0 | -225.14M | -192.27M | -1.96 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Invivyd Inc Stock (IVVD) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-04-05 | アップグレード | Guggenheim | Neutral → Buy |
2024-03-26 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2023-12-19 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
2023-05-01 | 開始されました | H.C. Wainwright | Buy |
Invivyd Inc (IVVD) 最新ニュース
What does recent volatility data suggest for Invivyd Inc.Earnings Miss & Smart Money Movement Tracker - Newser
Technical analysis overview for Invivyd Inc. stockJuly 2025 Opening Moves & Risk Controlled Swing Trade Alerts - Newser
How to escape a deep drawdown in Invivyd Inc.July 2025 Analyst Calls & Daily Technical Forecast Reports - Newser
Could Invivyd's (IVVD) New Study Design Hint at a Pivotal Strategy for Tackling Long COVID? - simplywall.st
Could Invivyd's (IVVD) Expanding Antibody Pipeline Redefine Its Long-Term Therapeutic Strategy? - Yahoo Finance
Does Invivyd Inc. stock have upside surprise potentialWeekly Trend Summary & Proven Capital Preservation Tips - خودرو بانک
Is Invivyd Inc. gaining market shareJuly 2025 Opening Moves & Technical Analysis for Trade Confirmation - خودرو بانک
Why is Invivyd Inc. stock going upTrade Exit Summary & Detailed Earnings Play Strategies - خودرو بانک
Analyzing recovery setups for Invivyd Inc. investorsJuly 2025 Trends & Safe Capital Growth Tips - Newser
Custom watchlist performance reports with Invivyd Inc.Global Markets & Long-Term Safe Investment Plans - Newser
Can Invivyd Inc. hit a new high this monthWeekly Gains Summary & Smart Money Movement Alerts - Newser
Has Invivyd Inc. formed a bullish divergenceMarket Movement Recap & Community Driven Trade Alerts - Newser
Price momentum metrics for Invivyd Inc. explainedJuly 2025 Opening Moves & Free Weekly Watchlist of Top Performers - Newser
Will Invivyd Inc. bounce back from current supportTrade Performance Summary & Precise Buy Zone Tips - Newser
Is Invivyd Inc. impacted by rising rates2025 Investor Takeaways & Real-Time Volume Spike Alerts - خودرو بانک
Senior Manager/Associate Director, Marketing Waltham/Bostonwill consider remo at Invivyd - Mediabistro
Analyzing Invivyd Inc. with risk reward ratio chartsJuly 2025 Action & Expert Curated Trade Setups - Newser
Can technical indicators confirm Invivyd Inc.’s reversal2025 Trading Recap & Growth Focused Entry Reports - Newser
Volume spikes in Invivyd Inc. stock – what they mean2025 Major Catalysts & Community Trade Idea Sharing - Newser
Should you avoid Invivyd Inc. stock right nowEarnings Recap Report & Capital Protection Trade Alerts - 강소기업뉴스
Chart based exit strategy for Invivyd Inc.Weekly Investment Summary & Stock Market Timing Techniques - Newser
Is now a turning point for Invivyd Inc.July 2025 Opening Moves & Low Risk Entry Point Guides - Newser
RA CAPITAL MANAGEMENT, L.P. Acquires Significant Stake in Invivyd Inc - GuruFocus
Market reaction to Invivyd Inc.’s recent newsJuly 2025 EndofMonth & Safe Entry Trade Reports - Newser
Trend analysis for Invivyd Inc. this weekMarket Activity Summary & Breakout Confirmation Alerts - Newser
Invivyd, Inc. Announces SPEAR Study Group's Proposal for Clinical Study on Monoclonal Antibodies for Long COVID Treatment - Quiver Quantitative
SPEAR Study Group to Present its Recommended Long COVID Antibody Study Design Featuring Invivyd’s VYD2311 At RECOVER-TLC Workshop September 9-10, 2025 - The Manila Times
Invivyd's VYD2311 to be Tested in Recommended Long COVID Antibody Study Design - AInvest
Is Invivyd Inc. still a buy after recent gainsJuly 2025 Highlights & AI Powered Market Entry Strategies - خودرو بانک
What machine learning models say about Invivyd Inc.2025 Trade Ideas & Safe Entry Momentum Stock Tips - Newser
Understanding Invivyd Inc.’s price movementMarket Performance Summary & AI Driven Price Forecasts - Newser
Invivyd at Cantor Global Healthcare: Strategic Moves in COVID-19 Antibody Space - Investing.com
Will Invivyd Inc. see short term momentumPortfolio Value Report & Free Weekly Watchlist of Top Performers - Newser
How to monitor Invivyd Inc. with trend dashboardsQuarterly Portfolio Summary & Daily Entry Point Alerts - Newser
Pattern recognition hints at Invivyd Inc. upsideWeekly Volume Report & AI Forecast for Swing Trade Picks - Newser
What analysts say about Invivyd Inc. stockJuly 2025 Weekly Recap & Long-Term Safe Investment Ideas - خودرو بانک
Long term hold vs stop loss in Invivyd Inc.Oil Prices & AI Optimized Trading Strategy Guides - Newser
Live market analysis of Invivyd Inc.2025 Trading Volume Trends & Real-Time Volume Surge Alerts - Newser
Applying Elliott Wave Theory to Invivyd Inc.July 2025 Retail & Risk Managed Investment Signals - Newser
How high can Invivyd Inc. stock goEntry Point & AI Powered Market Entry Ideas - Newser
Invivyd Inc (IVVD) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):